Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Operating Leases (2022 - 2023)

Cullinan Therapeutics (CGEM) has 2 years of Operating Leases data on record, last reported at $2.4 million in Q3 2023.

  • For Q3 2023, Operating Leases fell 38.73% year-over-year to $2.4 million; the TTM value through Sep 2023 reached $2.4 million, down 38.73%, while the annual FY2022 figure was $3.6 million, N/A changed from the prior year.
  • Operating Leases reached $2.4 million in Q3 2023 per CGEM's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Operating Leases topped out at $4.0 million in Q3 2022 and bottomed at $596000.0 in Q2 2022.